-
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-free DNA in Patients With Non-Small Cell Lung Cancer
Author: Lee, Kirsty W. C.; Li, Molly S. C.; Gai, Wanxia; Lau, Yat Ming; Chan, Allen K. C.; Chan, Oscar S. H.; Lee, Chee Khoon; Yeung, Rebecca M. W.; Fung, Sherwood Y. H.; Cheung, Wai F. F.; Chan, Vivian W. W.; Leung, Linda; Kam, Kenny N. P.; Mok, Tony S. K.
Journal: JAMA ONCOLOGY. 2023; Vol. 9, Issue 2, pp. 261-265. DOI: 10.1001/jamaoncol.2022.6109
-
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials
Author: Socinski, Mark A.; Jotte, Robert M.; Cappuzzo, Federico; Nishio, Makoto; Mok, Tony S. K.; Reck, Martin; Finley, Gene G.; Kaul, Monika D.; Yu, Wei; Paranthaman, Nindhana; Bara, Ilze; West, Howard J.
Journal: JAMA ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1001/jamaoncol.2022.7711
-
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
Author: Chen, Simiao; Cao, Zhong; Prettner, Klaus; Kuhn, Michael; Yang, Juntao; Jiao, Lirui; Wang, Zhuoran; Li, Weimin; Geldsetzer, Pascal; Baernighausen, Till; Bloom, David E.; Wang, Chen
Journal: JAMA ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1001/jamaoncol.2022.7826
-
Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China.
Author: Chen XZ1.
Journal: JAMA Oncol. 2019 Jan 1;5(1):116-117. doi: 10.1001/jamaoncol.2018.5526.
-
Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Author: McCaw ZR1, Jiang F2, Wei LJ1.
Journal: JAMA Oncol. 2019 Jan 1;5(1):117-118. doi: 10.1001/jamaoncol.2018.5730.
-
Risk of Diabetes Associated With Cancer Development.
Author: Hu D1, Peng F2, Niu W3.
Journal: JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6619. [Epub ahead of print]
-
First-line Nivolumab Plus Ipilimumab vs Sunitinib for Metastatic Renal Cell Carcinoma: A Cost-effectiveness Analysis.
Author: Wan X1,2, Zhang Y1,2, Tan C1,2, Zeng X3, Peng L1,2.
Journal: JAMA Oncol. 2019 Feb 21. doi: 10.1001/jamaoncol.2018.7086. [Epub ahead of print]
-
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer.
Author: Liu B1, Dong K1, Dong R1.
Journal: JAMA Oncol. 2019 Feb 21. doi: 10.1001/jamaoncol.2018.7217. [Epub ahead of print]
